Development Level

Tchem 58 | 1,890
Tbio 41 | 10,625
Tclin 28 | 602
Tdark 4 | 7,003

IMPC Term

preweaning lethality, complete... 6 | 633
preweaning lethality, incomple... 6 | 260
decreased lean body mass 5 | 195
increased lean body mass 5 | 107
decreased body weight 4 | 174
decreased grip strength 4 | 123
decreased total body fat amoun... 4 | 186
abnormal behavior 3 | 226
increased circulating HDL chol... 3 | 63
increased circulating choleste... 3 | 53
abnormal bone structure 2 | 131
abnormal lens morphology 2 | 73
abnormal retina morphology 2 | 100
abnormal tooth morphology 2 | 24
decreased bone mineral content 2 | 157
decreased circulating alkaline... 2 | 41
decreased circulating sodium l... 2 | 18
decreased total retina thickne... 2 | 20
embryonic lethality prior to o... 2 | 148
embryonic lethality prior to t... 2 | 187
immune system phenotype 2 | 17
increased blood urea nitrogen ... 2 | 44
increased body weight 2 | 42
increased circulating alkaline... 2 | 119
increased erythrocyte cell num... 2 | 26
limb grasping 2 | 35
persistence of hyaloid vascula... 2 | 22
tremors 2 | 34
abnormal QRS complex 1 | 25
abnormal bone mineralization 1 | 55
abnormal coping response 1 | 12
abnormal digit morphology 1 | 13
abnormal epididymis morphology 1 | 31
abnormal gait 1 | 51
abnormal limb bud morphology 1 | 15
abnormal limb morphology 1 | 7
abnormal optic disc morphology 1 | 10
abnormal retinal blood vessel ... 1 | 18
abnormal retinal inner nuclear... 1 | 5
abnormal retinal vasculature m... 1 | 15
abnormal skin morphology 1 | 23
abnormal tail morphology 1 | 17
absent startle reflex 1 | 15
absent teeth 1 | 4
cardiovascular system phenotyp... 1 | 35
cyanosis 1 | 6
decreased basophil cell number 1 | 11
decreased blood urea nitrogen ... 1 | 31
decreased circulating HDL chol... 1 | 77
decreased circulating LDL chol... 1 | 37
decreased circulating alanine ... 1 | 53
decreased circulating bilirubi... 1 | 14
decreased circulating choleste... 1 | 85
decreased circulating creatini... 1 | 31
decreased circulating glucose ... 1 | 121
decreased circulating insulin ... 1 | 75
decreased circulating magnesiu... 1 | 11
decreased circulating serum al... 1 | 79
decreased circulating total pr... 1 | 41
decreased circulating triglyce... 1 | 83
decreased effector memory CD8-... 1 | 24
decreased exploration in new e... 1 | 9
decreased heart rate variabili... 1 | 11
decreased heart weight 1 | 44
decreased neutrophil cell numb... 1 | 37
decreased prepulse inhibition 1 | 52
edema 1 | 11
enlarged epididymis 1 | 27
enlarged heart 1 | 111
hemorrhage 1 | 12
hydrops fetalis 1 | 22
hypoactivity 1 | 89
increased bone mineral content 1 | 92
increased circulating LDL chol... 1 | 15
increased circulating bilirubi... 1 | 16
increased circulating chloride... 1 | 43
increased circulating free fat... 1 | 17
increased circulating iron lev... 1 | 25
increased circulating magnesiu... 1 | 10
increased circulating phosphat... 1 | 24
increased circulating sodium l... 1 | 71
increased circulating triglyce... 1 | 24
increased fasted circulating g... 1 | 68
increased grip strength 1 | 83
increased hematocrit 1 | 36
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 25
increased or absent threshold ... 1 | 128
increased rib number 1 | 41
increased spleen weight 1 | 3
increased startle reflex 1 | 38
increased total body fat amoun... 1 | 57
oligodactyly 1 | 14
polycystic kidney 1 | 9
premature death 1 | 5
respiratory system phenotype 1 | 2
straub tail 1 | 26
thrombocytopenia 1 | 46

Disease

Toxic encephalopathy 131 | 131
ovarian cancer 8,484 | 8,484
osteosarcoma 7,933 | 7,933
psoriasis 6,685 | 6,685
medulloblastoma, large-cell 6,234 | 6,234
glioblastoma 5,572 | 5,572
lung cancer 4,466 | 4,466
atypical teratoid / rhabdoid tumor 4,369 | 4,369
intraductal papillary-mucinous neoplasm (IPMN) 3,289 | 3,289
malignant mesothelioma 3,162 | 3,162
Breast cancer 3,094 | 3,094
pilocytic astrocytoma 3,086 | 3,086
primitive neuroectodermal tumor 3,031 | 3,031
intraductal papillary-mucinous carcinoma (IPMC) 2,988 | 2,988
intraductal papillary-mucinous adenoma (IPMA) 2,956 | 2,956
invasive ductal carcinoma 2,950 | 2,950
oligodendroglioma 2,849 | 2,849
lung carcinoma 2,844 | 2,844
non-small cell lung cancer 2,798 | 2,798
lung adenocarcinoma 2,713 | 2,713
pediatric high grade glioma 2,712 | 2,712
ependymoma 2,514 | 2,514
Cancer 2,346 | 2,346
pancreatic cancer 2,300 | 2,300
interstitial cystitis 2,299 | 2,299
subependymal giant cell astrocytoma 2,287 | 2,287
group 3 medulloblastoma 2,254 | 2,254
astrocytic glioma 2,241 | 2,241
adult high grade glioma 2,148 | 2,148
Carcinoma 2,147 | 2,147
ulcerative colitis 2,087 | 2,087
pituitary cancer 1,972 | 1,972
Pick disease 1,893 | 1,893
group 4 medulloblastoma 1,875 | 1,875
pancreatic ductal adenocarcinoma liver metastasis 1,795 | 1,795
ductal carcinoma in situ 1,745 | 1,745
cystic fibrosis 1,665 | 1,665
diabetes mellitus 1,663 | 1,663
breast carcinoma 1,614 | 1,614
tuberculosis 1,557 | 1,557
posterior fossa group B ependymoma 1,530 | 1,530
medulloblastoma 1,524 | 1,524
posterior fossa group A ependymoma 1,511 | 1,511
astrocytoma 1,493 | 1,493
sonic hedgehog group medulloblastoma 1,482 | 1,482
colon cancer 1,475 | 1,475
adrenocortical carcinoma 1,427 | 1,427
Multiple myeloma 1,327 | 1,327
primary pancreatic ductal adenocarcinoma 1,271 | 1,271
juvenile dermatomyositis 1,189 | 1,189
Rheumatoid Arthritis 1,160 | 1,160
acute quadriplegic myopathy 1,157 | 1,157
atypical teratoid/rhabdoid tumor 1,095 | 1,095
spina bifida 1,064 | 1,064
cutaneous lupus erythematosus 1,056 | 1,056
nasopharyngeal carcinoma 1,056 | 1,056
Atopic dermatitis 944 | 944
dermatomyositis 933 | 933
active Crohn's disease 918 | 918
non primary Sjogren syndrome sicca 840 | 840
gastric carcinoma 832 | 832
primary Sjogren syndrome 789 | 789
acute myeloid leukemia 780 | 780
Waldenstrons macroglobulinemia 765 | 765
esophageal adenocarcinoma 737 | 737
tuberculosis and treatment for 6 months 686 | 686
progressive supranuclear palsy 674 | 674
aldosterone-producing adenoma 664 | 664
Alzheimer's disease 644 | 644
Obesity 616 | 616
Duchenne muscular dystrophy 602 | 602
Intellectual disability 573 | 573
pancreatic carcinoma 567 | 567
fibroadenoma 557 | 557
Down syndrome 548 | 548
Endometriosis 535 | 535
hepatocellular carcinoma 532 | 532
chronic rhinosinusitis 512 | 512
Schizophrenia 501 | 501
autosomal dominant Emery-Dreifuss muscular dystrophy 499 | 499
Multiple Sclerosis 498 | 498
mucosa-associated lymphoid tissue lymphoma 480 | 480
active ulcerative colitis 477 | 477
Prostatic Neoplasms 471 | 471
IGA Glomerulonephritis 454 | 454
Amyotrophic Lateral Sclerosis 431 | 431
gastric cancer 430 | 430
non-small cell lung carcinoma 413 | 413
Mammary Neoplasms 410 | 410
inflammatory breast cancer 404 | 404
Kidney disease 396 | 396
Neurodegenerative disease 383 | 383
Parkinson's disease 364 | 364
sarcoidosis 358 | 358
Asthma 349 | 349
glioblastoma multiforme 347 | 347
Epilepsy 346 | 346
Polycystic Ovary Syndrome 332 | 332
nephrosclerosis 329 | 329
tuberculosis and treatment for 3 months 327 | 327
Autistic Disorder 320 | 320

Tissue

Blood and immune system 130 | 17,995
Digestive Tract 130 | 18,473
Endocrine System 130 | 18,512
Female tissues 130 | 18,647
Liver and Pancreas 130 | 18,136
Nervous System 130 | 18,561
Urinary Tract 130 | 18,444
Cardiovascular System 129 | 17,958
Male tissues 129 | 17,969
Respiratory system 129 | 17,484
Skin and soft tissues 128 | 18,115

Target Family

Non-IDG 51 | 11,971
Enzyme 41 | 4,146
Kinase 10 | 634
Ion Channel 8 | 341
GPCR 7 | 406
Transcription Factor 7 | 1,400
Transporter 7 | 473

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Proto-oncogene c-Fos FOS Tchem Transcription Factor -4.11560 13094.7 961
Interleukin-1 beta IL1B Tclin Non-IDG -4.34333 22444.2 1345
Apolipoprotein E APOE Tbio Non-IDG -4.17470 15380.4 788
Glial cell line-derived neurotrophic factor GDNF Tbio Non-IDG -3.30206 2301.5 303
Neurofilament heavy polypeptide NEFH Tbio Non-IDG -2.73883 563.3 681
Myelin basic protein MBP Tbio Non-IDG -3.69577 5257.0 715
Glycogen synthase kinase-3 beta GSK3B Tclin Kinase -2.94349 567.7 767
Alpha-synuclein SNCA Tchem Non-IDG -3.59982 3997.3 1484
Group 10 secretory phospholipase A2 PLA2G10 Tchem Enzyme -2.39398 288.4 31
Prostaglandin G/H synthase 2 PTGS2 Tclin Enzyme -4.03668 12041.6 648